Client News
Filter by:
- Jul 17 2023 CEL-SCI Announces Proposed Public Offering of Common Stock
- Jul 14 2023 CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer
- Jul 11 2023 CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer
- Jun 22 2023 Movement Interactive, Powered by Iveda, Awarded Subcontract for the Veterans Affairs Remote Patient Monitoring Contract
- May 2 2023 Iveda and NetGain Systems Partner to Offer Observability-as-a-Service Capabilities to Cerebro Smart IoT Technology
- Mar 27 2023 Luokung Announces Issuing 5.5 Million Shares to Obtain $220 Million Strategic Investment
- Mar 21 2023 Luokung Announces 30-to-1 Share Combination
- Feb 3 2023 Motorsport Games Announces $4.03 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Feb 3 2023 Motorsport Games Announces Closings of $7.29 Million Registered Direct Offerings of Common Stock Priced At-the-Market Under Nasdaq Rules
- Feb 2 2023 Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9